Remel Inc. Instrumentation Package

This is a Notice of Intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested.

The National Institute of Health, Clinical Center (CC) intends to award a firm-fixed priced purchase order to REMEL, INC, Lenexa, KS 66215 on a sole source basis to acquire an Instrumentation Package to include the Sensititre™ ARIS HiQ™ System, SWIN Computer System, service maintenance along with various types of reagents and supplies. REMEL, INC is the only vendor/manufacturer that can provide the instrumentation package used for antimicrobial susceptibility testing of bacteria and yeast isolated in NIH patient cultures compatible with the TREK Sensititire™ System already existing within the NIH Clinical Center. The instrument, service, reagents, and supplies are the only ones that can meet the needs of clinical testing conducted by Microbiology Service. Since the supplies are proprietary, there is only one supplier whose products can fit into the instrumentation; any other supply or service could cause the cancellation of the protocol/delays in completion of the protocol. Any deviation from the protocol must be reported to the FDA for non-compliance. Department of Laboratory Medicine (DLM), Microbiology Service will telephone or e-mail request for required service, reagents, and supplies on a needed basis. Period of Performance shall be for a base year of twelve (12) months from the award date.

The estimated product list is attached to this notice and titled – Attachment 1 – List of Supplies 21-003625. The government reserves the right to increase quantities pursuant to FAR 52.217-6.

This acquisition is being conducted under the authority of the FAR Subpart 13.106-1(b)(1)(i) allowing the Contracting Officer (CO) to solicit from one source. Interested concerns capable of providing the same or similar products or services as described in this notice may submit a capability statement outlining their capabilities. Capability Statements must be received within the time set forth in this synopsis to be considered by the Government. A determination to compete this proposed contract based on responses to this notice is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement.

Each response should include the following Business Information:

a. DUNS.

b. Company Name, address, POC, Phone and Email address

c. Current GSA Schedules or NAICS codes appropriate to this Award.

d. Type of Company (i.e., small business, 8(a), woman owned, hubZone, veteran owned, etc.) as validated in System For Award Management (SAM). All offerors must register on the SAM located at http://www.sam.gov/portal/SAM/#1

e. Capability Statement

Comments to this announcement may be submitted to the Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, electronically to the attention of Kimala Winfield, kimala.winfield@nih.gov or Barbara Taylor, taylorb@cc.nih.gov by the due date and time marked in this notice.